Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8448333 | 1.00 | NAAA (0.58) | NAAACA12CA1CA2CA9 | |
| SCHEMBL17781743 | 0.90 | — | — | |
| SCHEMBL891412 | 0.83 | NAAA (0.50) | NAAACA12CA1CA2CA9 | |
| SCHEMBL27733980 | 0.80 | TSHR (0.57) | NAAACA12CA1CA2CA9 | |
| SCHEMBL4739657 | 0.80 | TSHR (0.57) | NAAACA12CA1CA2CA9 | |
| SCHEMBL27713564 | 0.80 | TSHR (0.57) | NAAACA12CA1CA2CA9 | |
| SCHEMBL11775344 | 0.80 | TSHR (0.57) | NAAACA12CA1CA2CA9 | |
| SCHEMBL6863758 | 0.80 | TSHR (0.57) | NAAACA12CA1CA2CA9 | |
| SCHEMBL6864269 | 0.80 | TSHR (0.57) | NAAACA12CA1CA2CA9 | |
| SCHEMBL246012 | 0.77 | NAAA (0.60) | NAAACA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113692288-A | Oil-in-water emulsion composition containing ultraviolet wavelength converting substance | 株式会社资生堂 | 2021-11-23 | — | — | CN | claimed |
| US-20210186829-A1 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | L'OREAL (FR) | 2021-06-24 | — | — | US | claimed |
| CN-111065372-A | Cosmetic base and skin cosmetic using the same | 株式会社资生堂 | 2020-04-24 | — | — | CN | claimed |
| EP-2254544-B1 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | OREAL (FR) | 2012-01-25 | — | — | EP | claimed |
| EP-2254544-A2 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | L'Oréal (FR) | 2010-12-01 | — | — | EP | claimed |
| WO-2009101113-A2 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | L'OREAL (FR) | 2009-08-20 | — | — | WO | claimed |
| CN-118234469-A | Composition and method for producing the same | 株式会社资生堂 | 2024-06-21 | — | — | CN | disclosed |
| CN-113692288-A | Oil-in-water emulsion composition containing ultraviolet wavelength converting substance | 株式会社资生堂 | 2021-11-23 | — | — | CN | disclosed |
| CN-113395981-A | External preparation for skin or mucosa, process for producing the same, and base for external preparation for skin or mucosa | 学校法人神奈川大学 | 2021-09-14 | — | — | CN | disclosed |
| US-20210186829-A1 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | L'OREAL (FR) | 2021-06-24 | — | — | US | disclosed |
| CN-107106490-B | Emulsified composition for producing aerosol and aerosol | 学校法人神奈川大学 | 2021-04-23 | — | — | CN | disclosed |
| US-10925815-B2 | Oil-in-water emulsion comprising an amphiphilic polymer | L'OREAL (FR) | 2021-02-23 | — | — | US | disclosed |
| CN-111867547-A | Pigment dispersion for cosmetic, and aqueous liquid cosmetic using same | 三菱铅笔株式会社 | 2020-10-30 | — | — | CN | disclosed |
| EP-2254544-B1 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | OREAL (FR) | 2012-01-25 | — | — | EP | disclosed |
| US-20110110989-A1 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | LOREAL (FR) | 2011-05-12 | — | — | US | disclosed |
| EP-2254544-A2 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | L'Oréal (FR) | 2010-12-01 | — | — | EP | disclosed |
| WO-2009101113-A2 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | L'OREAL (FR) | 2009-08-20 | — | — | WO | disclosed |
| US-20080226577-A1 | Cosmetic product comprising silicone compounds and an amphiphilic polymer | L'OREAL (FR) | 2008-09-18 | — | — | US | disclosed |
| EP-1935399-A2 | Cosmetic product containing silicone compounds and an amphiphilic polymer | L'OREAL (FR) | 2008-06-25 | — | — | EP | disclosed |
| EP-0471866-A1 | Modified water-soluble cellulose ether | Shin-Etsu Chemical Co., Ltd. (JP) | 1992-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210186829-A1 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | NAPEPLD, PHOSPHO1, PLIN5 | NAAA 1254/4885CA12 2772/4885CA1 4567/4885 |
| US-10925815-B2 | Oil-in-water emulsion comprising an amphiphilic polymer | NAPEPLD, PHOSPHO1, PLIN5 | NAAA 1254/4885CA12 2772/4885CA1 4567/4885 |
| US-20080226577-A1 | Cosmetic product comprising silicone compounds and an amphiphilic polymer | KRT18, CUTA, MITF | NAAA 1566/4885CA12 1722/4885CA1 1982/4885 |
| US-20110110989-A1 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER | NAPEPLD, PHOSPHO1, PLIN5 | NAAA 1254/4885CA12 2772/4885CA1 4567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.